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Purpose of the study
To understand the relationship between HAART and
preterm delivery (PTD).
Methods
Analysis of prospectively collected data from all patients
attending HIV antenatal services at a single UK centre
1995—2010. Fisher’s exact test two tailed for categorical
variables. T-test for continuous variables.
Results
Data are presented on all 324 deliveries up to 26/07/
2010. 78% of the women were Black African, 10.3%
Caucasian. Risk for HIV infection was heterosexual
intercourse in 94%, injecting drug use in 1.2%. Median
gestational age at first ante-natal clinic appointment was
13 weeks. 7 women took no therapy prior to delivery
and 7 took dual NRTI treatment. Data on the remainder
are summarised in Table 1
Delivery before 37 weeks (PTD) occurred in 14.4%
pregnancies of which 62% (8.8% of all pregnancies)
before 34 weeks. Difference not significant comparing
PTD in patients starting new continuous HAART
(17.2%) with pre-conception HAART (12.6%). PTD
occurred in 17/142 (12.%) women treated with nevira-
pine-based HAART compared with 24/102 (23.5%)
treated with protease inhibitor (PI)-based HAART (p
0.02). Of the 64 patients treated with a short-course of
HAART (START) during pregnancy to prevent mother-
to-child HIV transmission 33 were eligible, if willing to
delivery by pre-labour caesarean section (PLCS) to
receive zidovudine monotherapy (ZDVm) according to
the 2008 BHIVA guidelines1. Of these 10 had a preterm
delivery (30.3%).
Conclusions
The role of HAART and PI-based HAART in PTD has
been controversial. Even in this single-centre study,
where all women were managed by one team in accor-
dance with national guidelines, confounders abound.
CD4 counts and viral loads differed significantly
between patients starting HAART in pregnancy and
those taking ZDVm or already on HAART at concep-
tion. We therefore compared PTD rates in women who
were eligible for, and chose between, START (and the
potential of a normal vaginal delivery) and ZDVm with
PLCS. The rates of PTD were significantly higher (p
0.005)with START (30.3%) than with ZDVm (6.6%) in
these ZDVm eligible mothers. These data suggest that
PI-based HAART initiated during pregnancy is asso-
ciated with a significantly increased rate of PTD and
that this is influenced by maternal immune status.
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Table 1
Treatment Number Median CD4 /μL (Baseline ANC) Median HIV viral load/ml PTD Number (%)
Zidovudine monotherapy 61 445 2513 4 (6.6%)
START 64 360 8930 16 (25%)
new continuous HAART 58 150 23430 10 (17.2%)
pre-conception HAART 127 385 49 16 (12.6%)
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Further investigation to determine whether other regi-
mens may have less impact on PTD are urgently
required particularly with the increasing use of HAART
in prevention of mother-to-child transmission.
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